ArticleJournal of diabetes and metabolic disorders2020
NDSP 05: Prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016-2017.
Article in Journal of diabetes and metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 44 citations in OpenAlex.
- m-Lifestyle Intervention for Employees (m-LIfE): protocol for a pilot cluster randomized controlled trial on cardiovascular disease prevention strategies.Pilot and feasibility studies · 2026Review
- Significance of Yoga for the Management of Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2025Review
- Investigation of Dyslipidemia and Lipid Profile Ratios Among Patients in Tertiary Care Hospitals.EJIFCC · 2025Article
- Urban health inequities and healthy longevity: traditional and emerging risk factors across the cities and policy implications.Aging clinical and experimental research · 2025Review
- Article
- Burden of cardiovascular disease attributable to risk factors in Pakistan: insight from Global Burden of Disease Study 2019.Proceedings (Baylor University. Medical Center) · 2025Article
- Gender Disparity in Lipid Testing Among Over 0.5 Million Adults from Pakistan: Females are Tested Much Later Despite Higher LDL-Cholesterol Levels.Global heart · 2025Article
- Phytochemicals profiling ofFood science & nutrition · 2024Article
- Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study.European journal of medical research · 2024Article
- Transcriptomic Analysis of Alzheimer's Disease Pathways in a Pakistani Population.Journal of Alzheimer's disease reports · 2024Article
- Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action.Hepatology forum · 2024Article
- Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh.BMC cardiovascular disorders · 2023Article
- Inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023Article
- Article
- Article
- Prevalence of Hypercholesterolemia and Awareness of Risk Factors, Prevention and Management Among Adults Visiting Referral Hospital in Ethiopia.Vascular health and risk management · 2023Article
- Inclisiran: a novel drug for the treatment of dyslipidemia.Annals of medicine and surgery (2012) · 2023Article
- Peroxisome Proliferator-Activated Receptor-α (International journal of molecular sciences · 2022Article
- Prevalence, awareness, treatment, and control of dyslipidemia and associated factors among adults in Jordan: Results of a national cross-sectional survey in 2019.Preventive medicine reports · 2022Article
- National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesDyslipidemia is a major risk issue for the development of cardiovascular disease. The aim of our study was to observe the pattern and prevalence of dyslipidemia in Pakistani population. METHODOLOGY: This is a sub analysis of a population based second National Diabetes Survey of Pakistan (NDSP) 2016-2017 in adults aged 20 years or above, carried out from February 2016 to August 2017 across Pakistan. Multi stage sampling technique was used for the stratification of population, based on rural and urban domains. District wise clusters and sub clusters were selected i.e. 27 and 46 in number. Subjects, consented to participate were requested to come after an overnight fast for anthropometric measurements, oral glucose tolerance test and fasting lipid profile (except for subjects with self-reported diabetes). Dyslipidemia was identified using Adult Treatment Panel III guidelines.
resultsA total of 10,834 subjects (43.8% male and 56.2% female) having mean age of 43.8 ± 14.0 years, participated in the survey. Of the subjects studied, 39.3% had hypercholesterolemia, 48.9% had hypertriglyceridemia, 39.7% had high LDL-C levels while 83.9% men and 90% women had low HDL levels. High cholesterol and triglyceride levels were highest in 50-59 years age group, while high LDL and low HDL was most common in 40-49 years age group. Diabetes, obesity and hypertension were found to be the significant determinants for dyslipidemia.
conclusionPrevalence of dyslipidemia seems to be very high in Pakistan, necessitating an urgent call for early screening and effective management through lifestyle intervention and appropriate lipid lowering drugs to prevent this important cardiovascular risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.